Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).
published in: ESMO Open
date of publication: 2016-01-01
main subject: phase III clinical trial, metastatic colorectal carcinoma
Cites articles 25
- 2013-05-01
- 1970-05-01
Date
Title
Article - wd:Q54002435